Transient overexpression of Pparγ2 and C/ebpα in mesenchymal stem cells induces brown adipose tissue formation

Regenerative Medicine

Volumn 8, Issue 3, 2013, Pages 295-308

  Sheyn, Dmitriy ^a,b   Pelled, Gadi ^a,b   Tawackoli, Wafa ^b   Su, Susan ^b   Ben David, Shiran ^b   Gazit, Dan ^a,b   Gazit, Zulma ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

adipogenesis; bioluminescent imaging; brown adipose tissue; MSCs; nucleofection

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BROWN ADIPOSE TISSUE; C EBP ALPHA GENE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC ENGINEERING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PPAR GAMMA 2 GENE; PRIORITY JOURNAL; TRANSIENT EXPRESSION;

ADIPOGENESIS; ADIPOSE TISSUE, BROWN; ANIMALS; BIOLOGICAL MARKERS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENETIC ENGINEERING; HEK293 CELLS; HUMANS; ION CHANNELS; LUMINESCENT MEASUREMENTS; MESENCHYMAL STROMAL CELLS; MICE; MITOCHONDRIAL PROTEINS; ORGANOGENESIS; PPAR GAMMA; TRANSFECTION;

EID: 84876902276     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.13.25     Document Type: Article

References (62)

1. Sheyn D, Mizrahi O, Benjamin S, Gazit Z, Pelled G, Gazit D. Genetically modified cells in regenerative medicine and tissue engineering. Adv. Drug Deliv. Rev. 62(7-8), 683-698 (2010).
2. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84(1), 277-359 (2004).
3. Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes. Rev. 12(3), 167-188 (2010).
4. Tanzi MC, Fare S. Adipose tissue engineering: state of the art, recent advances and innovative approaches. Expert Rev. Med. Devices 6(5), 533-551 (2009).
5. Patrick CW Jr. Adipose tissue engineering: the future of breast and soft tissue reconstruction following tumor resection. Semin. Surg. Oncol. 19(3), 302-311 (2000).
6. Tseng YH, Kokkotou E, Schulz TJ et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454(7207), 1000-1004 (2008).
7. Vegiopoulos A, Muller-Decker K, Strzoda D et al. Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes. Science 328(5982), 1158-1161 (2010).
8. Seale P, Bjork B, Yang W et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454(7207), 961-967 (2008).
9. Ahfeldt T, Schinzel RT, Lee YK et al. Programming human pluripotent stem cells into white and brown adipocytes. Nat. Cell Biol. 14(2), 209-219 (2012).
10. Elabd C, Chiellini C, Carmona M et al. Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes. Stem Cells 27(11), 2753-2760 (2009).
11. Nedergaard J, Petrovic N, Lindgren EM, Jacobsson A, Cannon B. PPARgamma in the control of brown adipocyte differentiation. Biochim. Biophys. Acta 1740(2), 293-304 (2005).
12. Kang S, Bajnok L, Longo KA et al. Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol. Cell. Biol. 25(4), 1272-1282 (2005).
13. Kliewer SA, Forman BM, Blumberg B et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl Acad. Sci. USA 91(15), 7355-7359 (1994).
14. Mueller E, Drori S, Aiyer A et al. Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. J. Biol. Chem. 277(44), 41925-41930 (2002).
15. Kim SW, Her SJ, Kim SY, Shin CS. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts. Biochem. Biophys. Res. Commun. 327(3), 811-819 (2005).
16. Vernochet C, Peres SB, Davis KE et al. C/ebpalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor g agonists. Mol. Cell. Biol. 29(17), 4714-4728 (2009).
17. Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast. Surg. 32(1), 48-55 (2008).
18. Yoshimura K, Suga H, Eto H. Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation. Regen. Med. 4(2), 265-273 (2009).
19. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and -independent mechanisms. Cell Metab. 1(2), 93-106 (2005).
20. Chung HJ, Park TG. Injectable cellular aggregates prepared from biodegradable porous microspheres for adipose tissue engineering. Tissue Eng. Part A 15(6), 1391-1400 (2009).
21. Choi JS, Yang HJ, Kim BS et al. Human extracellular matrix (ECM) powders for injectable cell delivery and adipose tissue engineering. J. Control. Release 139(1), 2-7 (2009).
22. Stosich MS, Bastian B, Marion NW, Clark PA, Reilly G, Mao JJ. Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits. Tissue Eng. 13(12), 2881-2890 (2007).
23. Mauney JR, Volloch V, Kaplan DL. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Biomaterials 26(31), 6167-6175 (2005).
24. Alhadlaq A, Tang M, Mao JJ. Engineered adipose tissue from human mesenchymal stem cells maintains predefined shape and dimension: implications in soft tissue augmentation and reconstruction. Tissue Eng. 11(3-4), 556-566 (2005).
25. Neubauer M, Fischbach C, Bauer-Kreisel P et al. Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett. 577(1-2), 277-283 (2004).
26. Rim JS, Mynatt RL, Gawronska-Kozak B. Mesenchymal stem cells from the outer ear: a novel adult stem cell model system for the study of adipogenesis. FASEB J. 19(9), 1205-1207 (2005).
27. Mitchell JB, McIntosh K, Zvonic S et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24(2), 376-385 (2006).
28. Hamm A, Krott N, Breibach I, Blindt R, Bosserhoff AK. Efficient transfection method for primary cells. Tissue Eng. 8(2), 235-245 (2002).
29. Aslan H, Zilberman Y, Arbeli V et al. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng. 12(4), 877-889 (2006).
30. Aluigi M, Fogli M, Curti A et al. Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells 24(2), 454-461 (2006).
31. Dwivedi PP, Anderson PJ, Powell BC. Development of an efficient, non-viral transfection method for studying gene function and bone growth in human primary cranial suture mesenchymal cells reveals that the cells respond to BMP2 and BMP3. BMC Biotechnol. 12, 45 (2012).
32. Mizrahi O, Sheyn D, Tawackoli W et al. BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells. Gene Therapy 20(4), 370-377 (2013).
33. Nakashima S, Matsuyama Y, Nitta A, Sakai Y, Ishiguro N. Highly efficient transfection of human marrow stromal cells by nucleofection. Transplant Proc. 37(5), 2290-2292 (2005).
34. Sheyn D, Pelled G, Zilberman Y et al. Nonvirally engineered porcine adipose tissue-derived stem cells: use in posterior spinal fusion. Stem Cells 26(4), 1056-1064 (2008).
35. Zaragosi LE, Billon N, Ailhaud G, Dani C. Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells. Stem Cells 25(3), 790-797 (2007).
36. Ravussin E, Kozak LP. Have we entered the brown adipose tissue renaissance? Obes. Rev. 10(3), 265-268 (2009).
37. Valverde AM, Benito M, Lorenzo M. The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance. Acta Physiol. Scand. 183(1), 59-73 (2005).
38. Honigman A, Zeira E, Ohana P et al. Imaging transgene expression in live animals. Mol. Ther. 4(3), 239-249 (2001).
39. Arnon TI, Markel G, Bar-Ilan A et al. Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy. PLoS ONE 3(5), e2150 (2008).
40. Iris B, Zilberman Y, Zeira E et al. Molecular imaging of the skeleton: quantitative real-time bioluminescence monitoring gene expression in bone repair and development. J. Bone Miner. Res. 18(3), 570-578 (2003).
41. Sauma L, Stenkula KG, Kjolhede P, Stralfors P, Soderstrom M, Nystrom FH. PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids. Nutrition 22(1), 60-68 (2006).
42. Robinson CE, Wu X, Nawaz Z, Onate SA, Gimble JM. A corepressor and chicken ovalbumin upstream promoter transcriptional factor proteins modulate peroxisome proliferator-activated receptor-g2/retinoid X receptor a-activated transcription from the murine lipoprotein lipase promoter. Endocrinology 140(4), 1586-1593 (1999).
43. Clarke SL, Robinson CE, Gimble JM. CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor g 2 promoter. Biochem. Biophys. Res. Commun. 240(1), 99-103 (1997).
44. Choy L, Derynck R. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/ enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J. Biol. Chem. 278(11), 9609-9619 (2003).
45. Aslan H, Zilberman Y, Kandel L et al. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 24(7), 1728-1737 (2006).
46. Choi YS, Park SN, Suh H. Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials 26(29), 5855-5863 (2005).
47. Karacaoglu E, Kizilkaya E, Cermik H, Zienowicz R. The role of recipient sites in fat-graft survival: experimental study. Ann. Plast. Surg. 55(1), 63-68; discussion 68 (2005).
48. Sheyn D, Kallai I, Tawackoli W et al. Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. Mol. Pharm. 8(5), 1592-1601 (2011).
49. Lavon I, Goldberg I, Amit S et al. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kB activation. Nat. Med. 6(5), 573-577 (2000).
50. Sheyn D, Kimelman-Bleich N, Pelled G, Zilberman Y, Gazit D, Gazit Z. Ultrasound-based nonviral gene delivery induces bone formation in vivo. Gene Ther. 15(4), 257-266 (2008).
51. Hull D. The structure and function of brown adipose tissue. Br. Med. Bull. 22(1), 92-96 (1966).
52. Paganin-Gioanni A, Bellard E, Escoffre JM, Rols MP, Teissie J, Golzio M. Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells. Proc. Natl Acad. Sci. USA 108(26), 10443-10447 (2011).
53. Golzio M, Teissie J, Rols MP. Direct visualization at the single-cell level of electrically mediated gene delivery. Proc. Natl Acad. Sci. USA 99(3), 1292-1297 (2002).
54. McMahon JM, Conroy S, Lyons M et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev. 15(1), 87-96 (2006).
55. Kang Q, Song WX, Luo Q et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 18(4), 545-559 (2009).
56. Stosich MS, Mao JJ. Adipose tissue engineering from human adult stem cells: clinical implications in plastic and reconstructive surgery. Plast. Reconstr. Surg. 119(1), 71-83; discussion 84-75 (2007).
57. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 25(3), 750-760 (2007).
58. Moutsatsos IK, Turgeman G, Zhou S et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol. Ther. 3(4), 449-461 (2001).
59. Mori T, Sakaue H, Iguchi H et al. Role of Kruppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J. Biol. Chem. 280(13), 12867-12875 (2005).
60. Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil GS. Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol. Cell. Biol. 25(2), 706-715 (2005).
61. Christian M, Parker MG. The engineering of brown fat. J. Mol. Cell. Biol. 2(1), 23-25 (2010).
62. US NIH Guide for the Care and Use of Laboratory Animals. www.nap.edu/catalog.php?record-id=5140